PROMETRIKA

PROMETRIKA is an established, privately-held clinical research organization (CRO) with over two decades of experience supporting drug and device development. The company operates as a full-service partner, offering integrated solutions from strategic consulting and protocol design to regulatory submission and post-marketing studies, with noted specializations in rare diseases and oncology. Its business model is service-based, generating revenue by providing these clinical trial and development services to sponsor companies. PROMETRIKA leverages its mid-size structure to offer flexibility, responsiveness, and a collaborative partnership approach, particularly appealing to small and mid-sized biotechs.

Integrated clinical research service platform offering strategic consulting, protocol development, adaptive and decentralized trial design, data management (CDISC SDTM/ADaM), biostatistics, medical writing, pharmacovigilance, and regulatory submission support.

PROMETRIKA competes in a fragmented CRO market against large global players (e.g., IQVIA, ICON) and numerous smaller niche providers. Its differentiation is based on therapeutic expertise (especially rare diseases), a flexible partnership model, and a mid-size structure that balances scalability with personalized service.